Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 159,600
Avg Vol 23,512
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 33%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin r...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 8 6555 2945
Fax: 61 8 6210 1153
Address:
41-47 Colin Street, Suite 3, West Perth, Australia
Latest News on BXPHF
No data available.